title: Developing New Stroke Treatments Using Preclinical Randomized Controlled Trials.
authors.affiliation: Department of Neurosurgery, Mount Sinai Hospital, New York, New York, USA.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Kellner
authors.affiliation: Department of Neurosurgery, Mount Sinai Hospital, New York, New York, USA.
authors.forename: Ahmed J
authors.initials: AJ
authors.lastname: Awad
authors.affiliation: Department of Neurosurgery, Mount Sinai Hospital, New York, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Mocco
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D039441:Integrin alpha4 / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D039441:Integrin alpha4